Navigation Links
Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test
Date:8/22/2008

HAMBURG, Germany, August 22 /PRNewswire/ --

- Dangerous Bacteria Infect Three Million People in Europe Every Year

Sometimes something well-tried can also be innovative: already in Ancient Greece, copper was considered to be very antimicrobial. This ability is now playing an important role in the struggle against dangerous hospital germs. In a worldwide noted field test, a whole hospital ward at the Asklepios Clinic in Wandsbek in Hamburg, Germany, was equipped with door handles, door plates and light switches made of copper. Because the germs are not only transmitted from one hand to another but, in many cases, also by touching door handles and switches. At the moment, scientists at the University Halle-Wittenberg, Germany, are evaluating the samples of the first study phase. As a result, the Asklepios Clinic Wandsbek becomes the pioneer in this clinical research in Europe.

The main opponents are dangerous, antibiotic-resistant bacteria (MRSA), with which more and more patients worldwide fall ill in clinics and nursing homes. Classical sanitary measures are often insufficient to prevent a further spreading. According to the clinic and the involved scientists at the University Halle-Wittenberg, the first study results have shown "significantly less chances of survival" of microbes on copper surfaces, which is why the field test will be continued in the second half of the year. A complete evaluation is expected by early 2009.

Worldwide race against time

"The struggle against high-resistant agents cannot be won with the previous means, such as the use of new antibiotics and intensive disinfection measures. We must break new grounds in order to reduce the potential danger for our patients," Professor Prof. Dr. med. Jorg Braun, chief physician of the I. Medical Department at the Asklepios Clinic Wandsbek explains the motives for the field test. "Scientific tests performed by several independent working groups have shown beyond do
'/>"/>

SOURCE Asklepios Kliniken
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
4. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
5. June 2008 Mayo Clinic Womens HealthSource Highlights Shingles Vaccine for Pain Prevention, Tips to Avoid Antibiotic Resistant Infections, and Benefits of Broad Genetic Testing
6. Kosans Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial
7. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
8. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
9. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
10. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
11. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 1, 2015  Boston Scientific Corporation (NYSE: BSX ... momentum and long-term growth strategies at a meeting with ... City . President and Chief Executive Officer ... company has to bring forward meaningful innovation to transform ... deliver shareholder value. "We are focused ...
(Date:5/1/2015)... May 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... E. Morris , chief financial officer  will be participating ... are as follows: Mizuho Third Annual Healthcare ... Omni Berkshire Place, New York ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - Pivotal ... pharmaceutical company with a focus on Omega-3 therapies ... its operational highlights and financial results for the ... amounts referenced herein are in Canadian dollars unless ... have been significant, with the right strategic partners ...
Breaking Medicine Technology:Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6
... Bristol-Myers Squibb Company,(NYSE: BMY ) today announced ... accepted, for filing and review, the supplemental biologics,license ... of,pediatric patients with juvenile idiopathic arthritis (JIA) who ... disease-modifying anti-rheumatic drugs,(DMARDs) such as methotrexate (MTX) or ...
... of a pilot study,published in the Nutrition Journal ... hyperactivity disorder (ADHD) can benefit,from daily supplementation of ... demonstrated that children who consumed between 8 and ... long chain omega-3 fatty acids found in,fish oil) ...
Cached Medicine Technology:ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review 2ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review 3ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review 4Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD 2
(Date:5/2/2015)... 02, 2015 Kare Visits LLC. launched in ... busy caregivers. Kare Visits offers relief for caregivers by ... facilities. According to the Caregiver Action Network, eight ... of 20 hours a week caring for an elderly or ... to hire a nurse, a caregiver is now empowered to ...
(Date:5/2/2015)... 02, 2015 ZoomCare, the Portland-based innovator ... plans to offer its new healthcare insurance to individuals ... Personal Health Insurance System is the nation’s first health ... human performance. ZOOM+ Personal Health Insurance was ZoomCare’s first ... that are subject to review and regulation by the ...
(Date:5/1/2015)... (PRWEB) May 02, 2015 IDLife LLC, ... is proud to announce the addition of its newest ... is a life long athlete, growing up in gymnastics ... after college by becoming a personal trainer and helping ... the face of several TV shows highlighting her stunning ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Pioneer Millworks, ... share the latest in their reclaimed wood products at ... the Jacob Javits Center in NYC this May. Their ... will bring much anticipated texture and color to North ... an explosion of texture and color in the design ...
(Date:5/1/2015)... May 01, 2015 Royal River Natural ... Maine, reports on a new study that found two ... swelling and improved physical function as well as standard ... osteoarthritis of the knee. , The report is part ... for Well Being® ,” which Royal River Natural Foods ...
Breaking Medicine News(10 mins):Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2
... Jenifer Goodwin HealthDay Reporter , MONDAY, Sept. 13 ... thimerosal, a mercury-laden preservative that used to be found in ... infants exposed to only a little thimerosal, new research finds. ... that vaccination raises their children,s risk for autism, the researchers ...
... Sept. 13 (HealthDay News) -- Women can be vulnerable ... pregnancy, part of a condition called preeclampsia. And ... predict which women are most prone to preeclampsia in ... approach relies on so-called "metabolic profiling" to track telltale ...
... tests of mental aging reveals a good news-bad news situation. ... with age, to varying degrees. The good news is the ... to a study published by the American Psychological Association. ... and what,s called crystallized intelligence decline at older ages," said ...
... describing a newly developed pharmacological inhibitor is providing detailed ... in multiple human malignancies regulates a known tumor suppressor. ... 14th issue of the journal Cancer Cell , ... Mitogen-activated protein kinases (MAPKs) are enzymes that regulate multiple ...
... - A protein crucial for the immune response appears to ... form of childhood leukemia called T-cell acute lymphoblastic leukemia (T-ALL). ... the study shows, opening a potential avenue to new drugs ... by Iannis Aifantis, PhD, associate professor of pathology and director ...
... states, the European Union and a number of ... to make robots capable of serving as adaptable, ... people. The research project, known as ALIAS, places ... feelings of loneliness and isolation, and increasing activities ...
Cached Medicine News:Health News:More Evidence That Vaccines Don't Cause Autism 2Health News:More Evidence That Vaccines Don't Cause Autism 3Health News:Test Might Spot Women at High Risk for Pregnancy Complication 2Health News:Test Might Spot Women at High Risk for Pregnancy Complication 3Health News:New study reconciles conflicting data on mental aging 2Health News:New study reconciles conflicting data on mental aging 3Health News:Selective inhibition of BMK1 suppresses tumor growth 2Health News:NYU Langone scientists find key pathway implicated in progression of childhood cancer 2Health News:European partnership funds research toward robot aides for the elderly 2Health News:European partnership funds research toward robot aides for the elderly 3
Integra Epilepsy grid electrodes are thin and flexible for easier placement and to conform to the curvature of the cortical surface. Lead tunneling is done using a 14-gauge tunneling needle (ET-2)....
...
... Electrodes feature exceptional quality and design to ... seizure recording technology. Neurosurgeons worldwide consider these ... flexible available. Our electrodes come in many ... 4-contact strips to 64-contact grids. Their bodies ...
... designed for laboratories looking for time and ... system operation in terms of easy reagent ... and on-board stability., ,URISYS 2400 is ... walk-away capability for medium to high volume ...
Medicine Products: